EU Law weekly highlights—15 January 2026
This week's edition of EU Law weekly highlights includes analysis on the Court of Justice’s decision where the operator of an online marketplace on which an advertisement was placed was found not to have complied with its obligations under the EU’s General Data Protection Regulation, Myriad wins Unified Patent Court ruling as GXD-Bio breast cancer patent is revoked and the EU governments aim to reach a negotiating position by late March or early April 2026 on amendments to the EU’s AI Act following initial legislative discussions. In addition this week, the European Commission published a summary and the responses to the consultation on EU Digital Markets Act review, consults on the revisions to the EU REACH linked to restricted CMR substances, launched calls for evidence to inform the development of the European Ocean Act and on an initiative titled ‘Towards European open digital ecosystems’, seeking feedback on how to strengthen the EU open-source sector, announced that the new EU PFAS monitoring rules for drinking water have taken effect and the Parliament’s Transport and Tourism Committee voted to maintain and strengthen EU air passenger rights, rejecting Council of the EU’s proposals to weaken compensation rules.